Učitavanje...

Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas

CONTEXT. The oncolytic polio-rhinovirus recombinant (PVSRIPO) has demonstrated promise in currently ongoing phase I/II clinical trials against recurrent glioblastoma and was granted breakthrough therapy designation by the Food and Drug Administration/Center for Biologics Evaluation and Research. A r...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Arch Pathol Lab Med
Glavni autori: Chandramohan, Vidyalakshmi, Bryant, Jeffrey D., Piao, Hailan, Keir, Stephen T., Lipp, Eric S., Lefaivre, Michaela, Perkinson, Kathryn, Bigner, Darell D., Gromeier, Matthias, McLendon, Roger E.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6051547/
https://ncbi.nlm.nih.gov/pubmed/28829151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5858/arpa.2016-0580-OA
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!